Endologix Up 13% After Shipments Of Treatments For Aortic Disorders Resumed

Endologix, Inc. ELGX shares are trading higher by $0.72 (13 percent) at $6.05 in Thursday's session.

Investors are buying the issue based on the announcement the company has resumed shipments and procedures with its AFX and some sizes of its AFX2 products. Those products are used for the treatment of aortic disorders.

After a higher open, it had a brief retreat to $5.33, which matches Wednesday's close, and resumed its move higher. The ensuing rally took the issue to $6.45. That high coincides with Tuesday's high of $6.53.

Since reaching that level, it has fallen back and has been consolidating at the $6.00 area.